Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Background
Reverse-transcription polymerase chain reaction (RT-PCR) is a molecular biology technique used to detect RNA sequences by converting RNA into complementary DNA (cDNA) through reverse transcription and amplification using polymerase chain reaction (PCR). It is widely used in fields like virology, genetics, and diagnostic medicine particularly for detecting and analyzing RNA viruses like influenza, HIV, and SARS-CoV-2. Developed in the early 1980s, the process begins with reverse transcription, where reverse transcriptase converts RNA into cDNA. PCR then amplifies the cDNA using DNA primers to target specific sequences, producing millions of copies for analysis. RT-PCR offers high sensitivity and specificity and making it ideal for detecting low concentrations of RNA especially in viral infections. Its application has become essential in diagnostics particularly during outbreaks like the COVID-19 pandemic where it was used as a standard method for confirming SARS-CoV-2 infection.
Reverse transcription is a process that converts RNA into complementary DNA (cDNA) using the enzyme reverse transcriptase first discovered in the 1970s. This enzyme synthesizes a complementary DNA strand from an RNA template and revolutionizing the study of RNA and laying the groundwork for RT-PCR. In RT-PCR, reverse transcription serves as the initial step and converting RNA into cDNA which is more stable and efficient for amplification. The process uses a primer that binds to a region of the RNA and reverse transcriptase synthesizes the complementary strand of DNA.
PCR is invented by Kary Mullis in 1983 amplification of a specific DNA segment produces millions of copies through a series of thermal cycles. Originally developed for DNA amplification RT-PCR uses PCR to amplify cDNA generated from the RNA template allowing for exponential amplification and making it easier to detect and analyze even small amounts of RNA in a sample.
RT-PCR is a powerful tool in molecular diagnostics and research due to its high sensitivity, precision and versatility. It can detect low levels of RNA and making it ideal for early-stage infections or gene expression changes. It uses primers targeting specific RNA sequences ensuring high accuracy in detecting specific genes or viruses. Quantitative RT-PCR (qPCR) allows precise measurement of RNA levels and providing valuable data for gene expression analysis and viral load determination. RT-PCR can be applied to various samples making it a versatile diagnostic tool.
RT-PCR involves the extraction of RNA from a sample which can be from blood, tissue or cells. The RNA is then synthesized by reverse transcription which binds to a primer complementary to the RNA template. This creates a double-stranded cDNA molecule representing the RNA present in the sample. Primers are used to bind to the target region of the RNA and oligo(dT) primers, random primers or gene-specific primers are used.
The polymerase chain reaction (PCR) amplification process involves DNA denaturation, annealing and extension. The reaction temperature is raised to 50 to 65 °C for primers to bind to their complementary sequences and then raised to 68 to 72 °C for DNA polymerase to synthesize new DNA strands. This process is repeated for many cycles to amplify the target DNA sequence exponentially.
Detection and quantification of the cDNA can be done using methods like gel electrophoresis, fluorescence-based detection or quantitative PCR (qPCR) which monitors the amount of amplified product in real-time.
RT-PCR is a widely used and sensitive technique but it has limitations. It is highly sensitive and requiring careful preparation and amplification to avoid contamination. The process is technically complex and requiring precise optimization of reaction conditions like primer design and enzyme choice. Small changes can lead to inaccurate results. RT-PCR can be time-consuming and expensive especially for large-scale diagnostics or research projects. Despite advancements in qPCR, it still requires specialized equipment and expertise. Proper precautions and careful use are crucial to avoid contamination risks.
Indications/Applications
To detect the RNA-based pathogens: RT-PCR is a crucial diagnostic tool for RNA-based pathogens especially viruses. It is highly sensitive and can detect even minute amounts of viral RNA in clinical samples. RT-PCR is used globally for COVID-19 Diagnosis, HIV and Hepatitis C and influenza and respiratory viruses.
To detect the genetic mutations and variants: RT-PCR detects genetic mutations that affect the splicing or expression of genes. It is used in cancer diagnosis and monitoring, detecting gene fusions, mutations and overexpression of oncogenes in cancer cells. It is also used to detect mutations in genes responsible for inherited diseases.
Quantification of gene expression: RT-PCR is used in research to study gene expression. It is used for gene expression profiling, identifying potential therapeutic targets or biomarkers for diseases. It is used in drug development and toxicology studies to understand how cells respond to drug treatments at the molecular level.
Monitoring viral load: RT-PCR is critical for monitoring viral loads in patients with chronic viral infections. It provides valuable information about the progression of the infection, the effectiveness of treatment and the risk of transmission. In HIV treatment, RT-PCR is used to monitor the viral load of HIV RNA in patients receiving antiretroviral therapy (ART). In Hepatitis C and Hepatitis B, RT-PCR is used to monitor the viral load of hepatitis C and HBV in infected individuals.
Reference Range
Positive test results: There may be infectious disease like bacterial or viral.
Negative test results: There is no infection.
Interpretation
RT-PCR is a diagnostic tool used to detect the presence of RNA viruses like HIV, hepatitis C, influenza and SARS-CoV-2. The interpretation of these results depends on the presence or absence of the target RNA, the viral load (in quantitative tests) and the clinical presentation of the patient.
For COVID-19, positive results indicate the presence of SARS-CoV-2 RNA in the respiratory sample while negative results suggest no detectable viral RNA was found. Indeterminate results occur when the RT-PCR fails to produce a clear positive or negative outcome prompting a repeat test or further investigation.
In chronic infections like HIV and HCV, RT-PCR quantifies viral load and providing insights into the progression of the infection and the effectiveness of antiviral therapy. Positive results confirm active infection while negative results suggest no detectable viral RNA in the sample.
In influenza and other respiratory viruses, RT-PCR results are binary: either the pathogen is present or absent in the sample. Positive results indicate that the viral RNA is present in the patient’s respiratory tract confirming an active infection. Negative results suggest no detectable viral RNA in the sample.
Gene expression studies use RT-PCR to measure the expression levels of specific genes. Relative gene expression is expressed as a fold change comparing the expression in experimental conditions to a control or baseline condition. Normalization against stable housekeeping genes is critical for accurate interpretation. Internal controls are additional genes or conditions used to ensure the experimental conditions do not introduce bias or errors.
RT-PCR can also be used for genetic testing like detecting mutations, deletions or gene fusions associated with genetic diseases or cancers. The presence of mutations or variants confirms the presence of the genetic abnormality and may guide therapeutic decisions.
Collection And Panels
Sample type: Respiratory sample like nasopharyngeal, oropharyngeal swabs
Sample collection: Collect the sample by inserting a swab into the nasal or throat cavity.
Sample storage: Handl and transport the samples in a viral transport medium (VTM).
Sample type: Blood samples
Sample collection: Venipuncture
Sample collection tube: EDTA tube
Sample type: Urine
Sample collection container: Sterile plastic conainer
Sample type: Tissue or biopsy sample
Sample type: Saliva
Sample collection: Cotton swab or sterile collection tube
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
